 |
|
|
| |
Abacavir (ABC) use and risk of recurrent myocardial infarction (MI)
|
| |
| |
Reported by Jules Levin
CROI 2016 Feb 22-24 Boston
CA Sabin1, L Ryom2, A d’Arminio Monforte3, CI Hatleberg2, C Pradier4, O Kirk2, R Weber5, AN Phillips1, F Dabis6, M Law7, S de Wit8, P Reiss9, JD Lundgren2,
for the D:A:D Study Group
1Department of Infection and Population Health, UCL, London, UK; 2CHIP, Department of Infectious Diseases, Section 2100, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark; 3Dipartimento di Scienze della Salute, Clinica di Malattie Infectitive e Tropicali, Azienda Ospedaliera-Polo Universitario San Paolo, Milan Italy; 4Department of Public Health, Nice University Hospital, Nice, France, 5Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Switzerland; 6Université de Bordeaux, ISPED, Centre INSERM U897-Epidemiologie-Biostatistique, Bordeaux, France, 7The Kirby Institute, UNSW Australia, Sydney, Australia, 8Division of Infectious Diseases, Saint Pierre University Hospital, Université Libre de Bruxelles, Brussels, Belgium, 9Academic Medical Center, Dept. of Global Health and Div. of Infectious Diseases, University of Amsterdam, and HIV Monitoring Foundation, Amsterdam, The Netherlands
|
| |
|
|
|
|
|
